Background: To compare the structural outcome of intravitreal bevacizumab (IVB) and laser treatment for type 1 retinopathy of prematurity (ROP).

Methods: This is a retrospective comparative study. From December 2002 to April 2009, patients with type 1 ROP according to criteria of Early Treatment of Retinopathy of Prematurity (ETROP) study were treated by peripheral retinal diode laser photocoagulation in nearly confluent pattern. From May 2009 to January 2015, we performed IVB for patients with type 1 ROP. The patients were closely followed until disappearance of retinal neovascularization in the laser group and regression of avascular zone in the bevacizumab group. The demographical data, postmenstrual age (PMA) for treatment, and fundus findings were recorded by chart review. The difference between laser and bevacizumab groups was compared by Student t-test and Fisher exact test.

Results: We collected 43 patients (86 eyes) with type 1 ROP, including 30 male and 13 female infants. Their mean gestation age and birth body weight (BBW) were 27.5 weeks and 1,034 gm. Zone I and zone II disease were found in 8 and 35 patients. The mean PMA for treatment was 37.3 weeks. The mean follow-up period was 54.4 months. Laser treatment was administered in 26 patients, and bevacizumab injection for 17 infants. Single session of laser was performed in all patients of laser group without recurrence of retinal neovascularization. Complete regression of ROP was found in 15 infants of bevacizumab group following the first IVB. Four eyes in two patients (2/17, 11.7%) had recurrence of ROP and received additional injections and adjuvant laser treatment. There was no unfavorable anatomical results such as retinal detachment or macular ectopia or complications such as cataract or endophthalmitis in either bevacizumab or laser management.

Conclusions: Laser therapy and IVB were both effective treatments for type 1 ROP to cause favorable anatomical outcomes. Single session of laser ablation in nearly confluent pattern was sufficient for complete regression of ROP in laser group. Single IVB was appropriate for managing most of cases with ROP in bevacizumab group, but a small proportion (nearly one tenth) of them had recurrent episodes requiring adjuvant therapies.

Background: To compare the structural outcome of intravitreal bevacizumab (IVB) and laser treatment for type 1 retinopathy of prematurity (ROP).

Methods: This is a retrospective comparative study. From December 2002 to April 2009, patients with type 1 ROP according to criteria of Early Treatment of Retinopathy of Prematurity (ETROP) study were treated by peripheral retinal diode laser photocoagulation in nearly confluent pattern. From May 2009 to January 2015, we performed IVB for patients with type 1 ROP. The patients were closely followed until disappearance of retinal neovascularization in the laser group and regression of avascular zone in the bevacizumab group. The demographical data, postmenstrual age (PMA) for treatment, and fundus findings were recorded by chart review. The difference between laser and bevacizumab groups was compared by Student t-test and Fisher exact test.

Results: We collected 43 patients (86 eyes) with type 1 ROP, including 30 male and 13 female infants. Their mean gestation age and birth body weight (BBW) were 27.5 weeks and 1,034 gm. Zone I and zone II disease were found in 8 and 35 patients. The mean PMA for treatment was 37.3 weeks. The mean follow-up period was 54.4 months. Laser treatment was administered in 26 patients, and bevacizumab injection for 17 infants. Single session of laser was performed in all patients of laser group without recurrence of retinal neovascularization. Complete regression of ROP was found in 15 infants of bevacizumab group following the first IVB. Four eyes in two patients (2/17, 11.7%) had recurrence of ROP and received additional injections and adjuvant laser treatment. There was no unfavorable anatomical results such as retinal detachment or macular ectopia or complications such as cataract or endophthalmitis in either bevacizumab or laser management.

Conclusions: Laser therapy and IVB were both effective treatments for type 1 ROP to cause favorable anatomical outcomes. Single session of laser ablation in nearly confluent pattern was sufficient for complete regression of ROP in laser group. Single IVB was appropriate for managing most of cases with ROP in bevacizumab group, but a small proportion (nearly one tenth) of them had recurrent episodes requiring adjuvant therapies.

Background: To evaluate the inflammatory response after accelerated collagen cross-linking (CXL) in eyes with keratoconus.

Methods: Consecutive eyes with keratoconus undergoing CXL surgery were included in this nonrandomized interventional study. Aqueous flare was measured pre- and post-operatively with a laser flare photometer at 1 week, 1, 3 and 6 months after CXL.

Results: Sixty eyes of 60 patients were entered into the study. Before CXL, the mean flare value was 4.5 photons per millisecond (ph/ms). The flare values observed at week 1 (7.1 ph/ms; P=0.008), month 1 (6.5 ph/ms; P=0.04), month 3 (6.7 ph/ms; P=0.004) and month 6 (6.7 ph/ms; P=0.004) were significantly higher compared to baseline. Flare values were not significantly different from week 1 up to 6 months after CXL (P=0.930). No statistically significant correlation was detected between the amount of inflammation and keratometric indices.

Conclusions: Accelerated CXL in patients with keratoconus may cause a subclinical inflammatory response which is evident as slight but rather long-lasting rise of aqueous flare.

Background: To evaluate the inflammatory response after accelerated collagen cross-linking (CXL) in eyes with keratoconus.

Methods: Consecutive eyes with keratoconus undergoing CXL surgery were included in this nonrandomized interventional study. Aqueous flare was measured pre- and post-operatively with a laser flare photometer at 1 week, 1, 3 and 6 months after CXL.

Results: Sixty eyes of 60 patients were entered into the study. Before CXL, the mean flare value was 4.5 photons per millisecond (ph/ms). The flare values observed at week 1 (7.1 ph/ms; P=0.008), month 1 (6.5 ph/ms; P=0.04), month 3 (6.7 ph/ms; P=0.004) and month 6 (6.7 ph/ms; P=0.004) were significantly higher compared to baseline. Flare values were not significantly different from week 1 up to 6 months after CXL (P=0.930). No statistically significant correlation was detected between the amount of inflammation and keratometric indices.

Conclusions: Accelerated CXL in patients with keratoconus may cause a subclinical inflammatory response which is evident as slight but rather long-lasting rise of aqueous flare.

Background: Refractive errors are among the most frequent reasons for demand of eye-care services. Publications on refractive errors prevalence in our country are few. This study has the purpose to assess the prevalence of refractive errors in an adult population of Villa Maria, Córdoba, Argentina.

Methods: The Villa Maria Eye Study is a population-based cross-sectional study conducted in the city of Villa Maria, Córdoba, Argentina from May 2008 to November 2009. Subject’s aged 40+ received a demographic interview and complete ophthalmological exam. Visual acuity was obtained with an ETDRS chart. Cycloplegic auto refraction was performed. The spherical equivalent was highly correlated between right and left eyes, so only data of right eyes are presented. Myopia and hyperopia were defined with a ±0.50 diopters (D) criterion and astigmatism >1 D.

Results: This study included 646 subjects, aged 40 to 90 (mean age: 59.6±10.3 years old). Four hundred and sixty two (71.5%) were females. The mean spherical equivalent was +0.714±2.41 D (range, ?22.00 to +8.25 D) and the power of the cylinder was, on average, ?0.869±0.91 D (range, 0 to ?6.50 D). In this sample, 61.6% subjects were hyperopic, and 13.5% were myopic. Myopia prevalence was lower in men (9.8% versus 14.9%) but this difference among genders was not statistically significant. There were 141 subjects (21.8%) with anisometropia greater than 1 D, and 168 subjects (26.0%) with astigmatism greater than 1 D.

Conclusions: The present study shows the prevalence of cycloplegic refractive errors in an adult population of Argentina. The prevalence of hyperopia was high, while myopia prevalence was very low.

Background: Refractive errors are among the most frequent reasons for demand of eye-care services. Publications on refractive errors prevalence in our country are few. This study has the purpose to assess the prevalence of refractive errors in an adult population of Villa Maria, Córdoba, Argentina.

Methods: The Villa Maria Eye Study is a population-based cross-sectional study conducted in the city of Villa Maria, Córdoba, Argentina from May 2008 to November 2009. Subject’s aged 40+ received a demographic interview and complete ophthalmological exam. Visual acuity was obtained with an ETDRS chart. Cycloplegic auto refraction was performed. The spherical equivalent was highly correlated between right and left eyes, so only data of right eyes are presented. Myopia and hyperopia were defined with a ±0.50 diopters (D) criterion and astigmatism >1 D.

Results: This study included 646 subjects, aged 40 to 90 (mean age: 59.6±10.3 years old). Four hundred and sixty two (71.5%) were females. The mean spherical equivalent was +0.714±2.41 D (range, ?22.00 to +8.25 D) and the power of the cylinder was, on average, ?0.869±0.91 D (range, 0 to ?6.50 D). In this sample, 61.6% subjects were hyperopic, and 13.5% were myopic. Myopia prevalence was lower in men (9.8% versus 14.9%) but this difference among genders was not statistically significant. There were 141 subjects (21.8%) with anisometropia greater than 1 D, and 168 subjects (26.0%) with astigmatism greater than 1 D.

Conclusions: The present study shows the prevalence of cycloplegic refractive errors in an adult population of Argentina. The prevalence of hyperopia was high, while myopia prevalence was very low.

目的：通过光学相干断层扫描技术(optical coherence tomography，OCT)观察不同临床类型原发性闭角型青光眼(primary angle-closure glaucoma, PACG)行激光周边虹膜切开术(laser peripheral iris, LPI)前、后前房角开放距离变化，评价治疗效果。方法：选择明确诊断为PACG患者46例50眼，其中 急性闭角型青光眼临床前期及缓解期眼26例27眼，慢性闭角型青光眼20例23眼，行LPI治疗，通过OCT分别检查术前、术后2周距巩膜突500及750 μm处前房角开放距离，采用配对t检验。结果：急性闭角型青光眼LPI术前、术后2周前房角开放距离差异有统计学意义(P<0.05)；慢性闭角型青光眼术 前、术后2周前房角开放距离差异无统计学意义(P>0.05)。结论：急性闭角型青光眼LPI术后前房角开放距离增加，治疗效果较好；慢性闭角型青光眼LPI术后前房角开放距离增加不明显，术后仍存在前房角闭塞趋向。

Objective: To observe the anterior chamber angle opening distance before and after laser peripheral iris (LPI) in patients with different clinical types of primary angle closure glaucoma (PACG) by using optical coherence tomography (OCT), and evaluate the effect of the treatment. Methods: Selected 46 cases (50 eyes) of patients with PACG, including 26 cases (27 eyes) of acute angle closure glaucoma at the preclinical stage and remission phase of ocular and 20 cases (23 eyes) of chronic angle closure glaucoma, implemented LPI, examined the anterior chamber angle opening distance at the point of 500 and 750 μm from posterior to the scleral before and after surgery for 2 weeks by OCT, using a paired t-test. Results: Compared the anterior chamber angle opening distance before and after surgery for 2 weeks, the difference in patients with acute angle closure glaucoma was statistically significant (P<0.05), but not statistically significant in patients with chronic angle closure glaucoma (P>0.05). Conclusion: The opening distance of the anterior chamber angle of the patients with acute angle  closure glaucoma after LPI was increased, and the treatment effect was better; but of the patients with chronic angle closure glaucoma after LPI, the distance was not obviously increased, the tendency of anterior chamber angle occlusion still existed after LPI.

Background: Evaluation of corneal biomechanical properties 3 months after using rigid gas permeable (RGP) contact lenses in keratoconus.

Methods: In this prospective trial study, cases were 32 keratoconic eyes with no history of RGP lens wear. All eyes were examined with the Ocular Response Analyzer (ORA) and the Corneal Visualization Scheimpflug Technology (CORVIS-ST) to measure corneal hysteresis (CH), corneal resistance factor (CRF), deformation amplitude (DA), applanation velocity (AV) 1 and 2, applanation length (AL) 1 and 2, and peak distance before and 3 months after fitting aspheric RGP lenses. The effect of the correlation between contralateral eyes and maximum keratometry were controlled for in the analysis. Results were compared using repeated measures analysis of covariance.

Results: At 3 months, neither the increases in mean CH (0.14±2.77 mmHg, P=0.789), CRF (0.41±4.35 mmHg, P=0.612), AV1 (0.03±0.17 m/s, P=0.301), AV2 (0.11±0.59 m/s, P=0.299), AL1 (0.44±1.56 m/s, P=0.118), AL2 (1.16±5.06 m/s, P=0.211), and peak distance (0.19±1.29 m/s, P=0.409), nor the decrease in mean DA (0.03±0.17 mm, P=0.402) was statistically significant.

Conclusions: Results in our series of patients indicated that 3 months of RGP lens wear had no significant impact on corneal biomechanics, and perhaps non progression of keratoconus. Therefore, RGP lenses can be regarded safe and appropriate in keratoconic patients.

Background: Evaluation of corneal biomechanical properties 3 months after using rigid gas permeable (RGP) contact lenses in keratoconus.

Methods: In this prospective trial study, cases were 32 keratoconic eyes with no history of RGP lens wear. All eyes were examined with the Ocular Response Analyzer (ORA) and the Corneal Visualization Scheimpflug Technology (CORVIS-ST) to measure corneal hysteresis (CH), corneal resistance factor (CRF), deformation amplitude (DA), applanation velocity (AV) 1 and 2, applanation length (AL) 1 and 2, and peak distance before and 3 months after fitting aspheric RGP lenses. The effect of the correlation between contralateral eyes and maximum keratometry were controlled for in the analysis. Results were compared using repeated measures analysis of covariance.

Results: At 3 months, neither the increases in mean CH (0.14±2.77 mmHg, P=0.789), CRF (0.41±4.35 mmHg, P=0.612), AV1 (0.03±0.17 m/s, P=0.301), AV2 (0.11±0.59 m/s, P=0.299), AL1 (0.44±1.56 m/s, P=0.118), AL2 (1.16±5.06 m/s, P=0.211), and peak distance (0.19±1.29 m/s, P=0.409), nor the decrease in mean DA (0.03±0.17 mm, P=0.402) was statistically significant.

Conclusions: Results in our series of patients indicated that 3 months of RGP lens wear had no significant impact on corneal biomechanics, and perhaps non progression of keratoconus. Therefore, RGP lenses can be regarded safe and appropriate in keratoconic patients.

The present study reports a case of a patient with choroidal neovascularization (CNV) associated with pseudoxanthoma elasticum (PXE). We observed the functional and anatomical improvement of the patient treated with intravitreal vascular endothelial growth factor (VEGF) inhibitor bevacizumab. The study also systematically searched the database for similar cases to provide a literature review. Data concerning the clinical features, treatment strategies and outcomes were extracted and analyzed. Retrospective interventional case report and systematic literature review. A 56-year-old healthy Chinese woman with CNV secondary to PXE was reported. Examinations included best corrected visual acuity (BCVA), biomicroscopy, optical coherence tomography (OCT), fluorescein and indocyanine green angiography and digital fundus photography. The patient managed with intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections (bevacizumab 1.25 mg/0.05 mL). The Cochrane Library, PubMed, OVID, and UpToDate databases were searched using the term pseudoxanthoma elasticum or Gr?nblad-Strandberg syndrome with the limits English. Articles that predated the databases were gathered from current references. Fundus examination revealed angioid streaks bilaterally and CNV in left eye (LE). After the patient underwent three intravitreal injections of bevacizumab, the LE showed absorption of the subretinal fluid and shrinkage of the CNV. Visual acuity (VA) was improved in her treated LE. Bevacizumab treatment was well tolerated with no adverse events reported. Approximately ten articles about 45 patients (49 eyes) describing CNV secondary to angioid streaks in PXE treated with anti-VEGF were found in the literature search. In the present case, bevacizumab of an initial three injection loading dose, achieved maintenance of visual function in the treatment of CNV associated with angioid streaks in PXE. Literature articles concluded that the intravitreal application of anti-VEGF is highly efficient for improving and stabilizing the lesion as well as the eyesight. So we believe that anti-VEGF therapy can be a great choice of treatment for CNV secondary to angioid streaks related PXE.

The present study reports a case of a patient with choroidal neovascularization (CNV) associated with pseudoxanthoma elasticum (PXE). We observed the functional and anatomical improvement of the patient treated with intravitreal vascular endothelial growth factor (VEGF) inhibitor bevacizumab. The study also systematically searched the database for similar cases to provide a literature review. Data concerning the clinical features, treatment strategies and outcomes were extracted and analyzed. Retrospective interventional case report and systematic literature review. A 56-year-old healthy Chinese woman with CNV secondary to PXE was reported. Examinations included best corrected visual acuity (BCVA), biomicroscopy, optical coherence tomography (OCT), fluorescein and indocyanine green angiography and digital fundus photography. The patient managed with intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections (bevacizumab 1.25 mg/0.05 mL). The Cochrane Library, PubMed, OVID, and UpToDate databases were searched using the term pseudoxanthoma elasticum or Gr?nblad-Strandberg syndrome with the limits English. Articles that predated the databases were gathered from current references. Fundus examination revealed angioid streaks bilaterally and CNV in left eye (LE). After the patient underwent three intravitreal injections of bevacizumab, the LE showed absorption of the subretinal fluid and shrinkage of the CNV. Visual acuity (VA) was improved in her treated LE. Bevacizumab treatment was well tolerated with no adverse events reported. Approximately ten articles about 45 patients (49 eyes) describing CNV secondary to angioid streaks in PXE treated with anti-VEGF were found in the literature search. In the present case, bevacizumab of an initial three injection loading dose, achieved maintenance of visual function in the treatment of CNV associated with angioid streaks in PXE. Literature articles concluded that the intravitreal application of anti-VEGF is highly efficient for improving and stabilizing the lesion as well as the eyesight. So we believe that anti-VEGF therapy can be a great choice of treatment for CNV secondary to angioid streaks related PXE.

眼科日间手术显著提高了医疗效率、节约了医疗资源，眼科麻醉复苏体系的建立则是眼科日间全身麻醉手术的重要安全保障，也是提高眼科手术室效率的重要举措。在眼科手术结束后，全身麻醉患者被即刻转运至麻醉恢复室(post-anesthesia care unit, PACU)，此时患者仍处于麻醉状态，密切的监测和呼吸机辅助通气是必不可少的，从而保障患者从麻醉状态逐渐恢复至清醒状态。当患者清醒后，拔除喉罩，各项监测指标达到PACU的转出标准，可进入到Ⅱ期复苏并日间手术离院。然而，在PACU复苏期间，患者易出现喉罩移位、呛咳等引起急性缺氧等呼吸道不良事件的发生，小儿患者则由于术后眼罩遮盖等原因，出现苏醒期躁动的概率高，从而影响到患者顺利转出PACU，间接影响到手术患者的周转。因此，如何预防这些并发症的发生，对提高眼科麻醉复苏质量显得十分重要。

眼科日间手术显著提高了医疗效率、节约了医疗资源，眼科麻醉复苏体系的建立则是眼科日间全身麻醉手术的重要安全保障，也是提高眼科手术室效率的重要举措。在眼科手术结束后，全身麻醉患者被即刻转运至麻醉恢复室(post-anesthesia care unit, PACU)，此时患者仍处于麻醉状态，密切的监测和呼吸机辅助通气是必不可少的，从而保障患者从麻醉状态逐渐恢复至清醒状态。当患者清醒后，拔除喉罩，各项监测指标达到PACU的转出标准，可进入到Ⅱ期复苏并日间手术离院。然而，在PACU复苏期间，患者易出现喉罩移位、呛咳等引起急性缺氧等呼吸道不良事件的发生，小儿患者则由于术后眼罩遮盖等原因，出现苏醒期躁动的概率高，从而影响到患者顺利转出PACU，间接影响到手术患者的周转。因此，如何预防这些并发症的发生，对提高眼科麻醉复苏质量显得十分重要。